Location
United States, North America
Check Size
$5M - $25M
Investment Stage
Seed
Series A
Focus Areas
Consumer Internet
AI
BioTech
Data Services
Enterprise
About Investor
John Hamer is Managing Partner at DCVC Bio (part of DCVC). DCVC focuses on deep tech, typically investing from Seed through Series A; public listings indicate typical checks in the ~$1M–$15M range. Hamer previously served as VP at Monsanto and Managing Director of Monsanto Growth Ventures, after earlier roles at Burrill & Company and as an entrepreneur at Paradigm Genetics.
Previous investments
Totus Medicines
66M |2023
CH4 Global
29M |2023
13M |2021
Solu Therapeutics
31M |2023
Similar Investors
RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,FB
Frank Balas
Canada, North America
$100K - $5M
Pre Seed
,Seed
,FF
Faraz Fatemi
United States, North America
$1M - $30M
Seed
,Series A
,VL
Vishal Lugani
United States, North America
$700K - $7M
Seed
,Series A
,AM
Alex Moore
United States, North America
$3M - $30M
Seed
,DR
Dylan Reid
United States, North America
$1M - $5M
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free